Watch CBS News

Food and Drug Administration

1013-ctm-blindnessgene-agus-1418703-640x360.jpg

Gene therapy for rare blindness

An experimental gene therapy for a rare hereditary form of blindness is a step closer to reality. An FDA advisory panel voted unanimously Thursday to recommend approval of a groundbreaking treatment for people with a faulty gene that impairs vision. It would be the first gene therapy in the U.S. for an inherited disease. Dr. David Agus joins "CBS This Morning" to discuss how the treatment works and why it could be a new frontier in treating genetic disorders.

Show More
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.